Clinical Trial Update: Reproducibility Study of OABSS and Its Response to Treatment [Phase 4]

View source ↗

Summary

A Phase 4 study by Astellas assesses the reproducibility of the Overactive Bladder Symptom Score (OABSS) and its response to treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED